Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies

Minny Bhatty, Shumei Kato, Sarina A. Piha-Paul, Aung Naing, Vivek Subbiah, Helen J. Huang, Daniel D. Karp, Apostolia M. Tsimberidou, Ralph G Zinner, Wen-Jen Hwu, Milind Javle, Sapna P. Patel, Mimi I. Hu, Gauri R. Varadhachary, Anthony P. Conley, Nishma M. Ramzanali, Veronica R. Holley, Razelle Kurzrock, Funda Meric-Bernstam, Young Kwang ChaeKevin B. Kim, Gerald S. Falchook, Filip Janku

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences